In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey

Clinical Microbiology and Infection

Volumn 8, Issue 4, 2002, Pages 240-242

  Kocagoz S ^a   Akova, M ^a   Altun, B ^a   Gur D ^a   Hascelik G ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRUCELLA MELITENSIS; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TURKEY (REPUBLIC);

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS;

EID: 0036526385     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00416.x     Document Type: Article

References (10)

1. Quinolones in treatment of human brucellosis: Comparative trial of ofloxacin-rifampin versus doxycycline-rifampin
2. Brucella
3. Antibacterial activity of lomefloxacin against Brucella melitensis
4. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones
5. In vitro activities of six new fluoroquinolones against Brucella melitensis
6. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs
7. Lack of effective bactericidal activity of new quinolones against Brucella spp
8. Brucella species
9. Ofloxacin in the treatment of brucellosis
10. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections